Reuters logo
2 months ago
BRIEF-Intellipharmaceutics announces FDA advisory committee meeting for rexista
June 30, 2017 / 8:27 PM / 2 months ago

BRIEF-Intellipharmaceutics announces FDA advisory committee meeting for rexista

June 30 (Reuters) - Intellipharmaceutics International Inc :

* Intellipharmaceutics announces FDA advisory committee meeting for rexista (oxycodone hydrochloride extended release), an abuse deterrent opioid analgesic for the treatment of moderate to severe pain

* Intellipharmaceutics International Inc - FDA set a target action date under prescription drug user fee act of September 25, 2017 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below